These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19796201)

  • 1. Omalizumab efficacy in a girl with atopic eczema.
    Caruso C; Gaeta F; Valluzzi RL; Romano A
    Allergy; 2010 Feb; 65(2):278-9. PubMed ID: 19796201
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study.
    Sheinkopf LE; Rafi AW; Do LT; Katz RM; Klaustermeyer WB
    Allergy Asthma Proc; 2008; 29(5):530-7. PubMed ID: 18926061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis.
    Incorvaia C; Pravettoni C; Mauro M; Yacoub MR; Tarantini F; Riario-Sforza GG
    Monaldi Arch Chest Dis; 2008 Jun; 69(2):78-80. PubMed ID: 18837422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
    Vignola AM; Humbert M; Bousquet J; Boulet LP; Hedgecock S; Blogg M; Fox H; Surrey K
    Allergy; 2004 Jul; 59(7):709-17. PubMed ID: 15180757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technology evaluation: omalizumab, Genentech/Novartis/Tanox.
    Lazaar AL
    Curr Opin Mol Ther; 2003 Feb; 5(1):81-9. PubMed ID: 12669476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-IgE therapy with omalizumab in asthma and allergic rhinitis.
    Dodig S; Richter D; Cepelak I; Benko B
    Acta Pharm; 2005 Jun; 55(2):123-38. PubMed ID: 16179127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.
    Holgate S; Casale T; Wenzel S; Bousquet J; Deniz Y; Reisner C
    J Allergy Clin Immunol; 2005 Mar; 115(3):459-65. PubMed ID: 15753888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD20 (rituximab) treatment for atopic eczema.
    Sedivá A; Kayserová J; Vernerová E; Poloucková A; Capková S; Spísek R; Bartůnková J
    J Allergy Clin Immunol; 2008 Jun; 121(6):1515-6; author reply 1516-7. PubMed ID: 18410962
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-immunoglobulin e in the treatment of refractory atopic dermatitis.
    Amrol D
    South Med J; 2010 Jun; 103(6):554-8. PubMed ID: 20710140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab: a novel monoclonal antibody for treatment of allergic disease.
    Piascik P
    J Am Pharm Assoc (Wash); 2002; 42(2):356, 358. PubMed ID: 11926671
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep disorders in patients with asthma, atopic dermatitis, and allergic rhinitis.
    Bender BG; Leung DY
    J Allergy Clin Immunol; 2005 Dec; 116(6):1200-1. PubMed ID: 16337445
    [No Abstract]   [Full Text] [Related]  

  • 13. [Allergic rhinitis and bronchial asthma. Stepwise plans for the treatment].
    Bischoff A
    MMW Fortschr Med; 2009 May; 151(19):18-9. PubMed ID: 19827437
    [No Abstract]   [Full Text] [Related]  

  • 14. Omalizumab for patients with severe and therapy-refractory atopic eczema?
    Andres C; Belloni B; Mempel M; Ring J
    Curr Allergy Asthma Rep; 2008 May; 8(3):179-80. PubMed ID: 18589835
    [No Abstract]   [Full Text] [Related]  

  • 15. Drugs for allergic disorders.
    Treat Guidel Med Lett; 2007 Aug; 5(60):71-80. PubMed ID: 17703144
    [No Abstract]   [Full Text] [Related]  

  • 16. Omalizumab (Xolair) in children with seasonal allergic rhinitis: leukotriene release as a potential in vitro parameter to monitor therapeutic effects.
    Kopp MV; Stenglein S; Kamin W; Friedrichs F; von Berg A; Zielen S; Hamelmann E; Wahn U; Kuehr J
    Pediatr Allergy Immunol; 2007 Sep; 18(6):523-7. PubMed ID: 17680911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels.
    Belloni B; Ziai M; Lim A; Lemercier B; Sbornik M; Weidinger S; Andres C; Schnopp C; Ring J; Hein R; Ollert M; Mempel M
    J Allergy Clin Immunol; 2007 Nov; 120(5):1223-5. PubMed ID: 17936892
    [No Abstract]   [Full Text] [Related]  

  • 18. The burden of atopy and asthma in children.
    O'Connell EJ
    Allergy; 2004 Aug; 59 Suppl 78():7-11. PubMed ID: 15245350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST; Djukanović R; Casale T; Bousquet J
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Seasonal allergic rhinitis. Ban the risk of asthma!].
    Kreutzkamp B
    MMW Fortschr Med; 2001 Apr; 143(15):12. PubMed ID: 11349311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.